Quantum BioPharma a annoncé mardi l'achat de 2 000 actions GameStop dans le cadre d'un investissement stratégique. La société a également indiqué avoir procédé à un règlement de ...

— Quantum BioPharma Ltd. , société biopharmaceutique engagée dans le développement de thérapies innovantes contre les ...

Investing.com -- L’action de Quantum BioPharma Ltd. (NASDAQ: QNTM) a chuté de 5,7% après que la société a annoncé l’achat de ...

“The Quantum team and I see the extreme value in GameStop going forward and the deep value the company has with 90% cash and marketable securities on their balance sheet,” said Kevin Malone, Board ...

Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...

Contacts: Quantum BioPharma Ltd. Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board Email: [email protected] Telephone: (833) 571-1811 Investor Relations ...

Quantum BioPharma - GlobeNewswire - Mon May 5, 6:08AM CDT To assist enquiries a copy of the amended complaint can be viewed by clicking the following link: Quantum Amended Court Claim ...

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Quantum ...

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari Dr. Raza Bokhari, Company’s Former CEO, Paid $2.35 Million USD in Non-Dilutive Cash to ...

Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of ...

TORONTO, April 22, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum BioPharma ” or the “ Company ”), is pleased to announce the appointment of Kevin ...

Quantum BioPharma (NASDAQ: QNTM) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and ...